Post your clinical trial on JoinClinicalTrials.com to reach thousands of viewer daily. Our Clinical Trial Listings have consistently proven to be an ...
Conditions: Glioblastoma Multiforme; Glioblastoma Intervention: Drug: Carvedilol Sponsors: West Virginia University; West Virginia Clinical and Translational Science Institute Recruiting
Conditions: Skin Lesion; Skin Cancer; Skin Melanoma; Tumor Skin Intervention: Other: Oxygen Sponsors: West Virginia University; West Virginia Clinical and Translational Science Institute; Mary Babb Randolph Cancer Center at West Virginia University Hospitals Recruiting
Condition: Lymphoma, Mantle Cell Interventions: Drug: Acalabrutinib in combination with bendamustine and rituximab; Drug: Placebo in combination with bendamustine and rituximab Sponsor: Acerta Pharma BV Recruiting
Conditions: Other Cancer; Gastrointestinal Cancer; Thoracic Cancer; Gynecologic Cancer Interventions: Other: eSyM App Usage; Other: SASS Questionnaire Sponsors: Dana-Farber Cancer Institute; National Cancer Institute (NCI); RTI International; Baptist Memorial Health Care Corporation; Dartmouth-Hitchcock Medical Center; Maine Medical Center; West Virginia University; Lifespan Recruiting
Conditions: Ischemic Stroke; Sleep Apnea; Sleep Apnea, Obstructive; TIA; Stroke; CPAP; Telemedicine; Home Sleep Apnea Test; Randomized Clinical Trial; Multicenter Trial Intervention: Device: CPAP Sponsors: University of Michigan; National Institute of Neurological Disorders and Stroke (NINDS); FusionHealth LLC; Medical University of South Carolina; University of Cincinnati Recruiting
Condition: Acute Ischemic Stroke Interventions: Drug: Argatroban; Drug: Eptifibatide; Drug: Placebo Sponsors: University of Cincinnati; National Institute of Neurological Disorders and Stroke (NINDS) Recruiting
Condition: Stage II Prostate Adenocarcinoma Interventions: Radiation: Intensity-Modulated Radiation Therapy (IMRT); Radiation: Stereotactic Body Radiation Therapy (SBRT) Sponsors: NRG Oncology; National Cancer Institute (NCI) Recruiting
Condition: Breast Screening Interventions: Procedure: Digital Mammography; Procedure: Digital Tomosynthesis Mammography; Other: Laboratory Biomarker Analysis Sponsors: ECOG-ACRIN Cancer Research Group; National Cancer Institute (NCI); Canadian Cancer Trials Group (CCTG) Recruiting
Conditions: Breast Adenocarcinoma; Metastatic Breast Carcinoma; Recurrent Breast Carcinoma; Stage III Breast Cancer AJCC v7; Stage IIIA Breast Cancer AJCC v7; Stage IIIB Breast Cancer AJCC v7; Stage IIIC Breast Cancer AJCC v7; Stage IV Breast Cancer AJCC v6 and v7 Interventions: Drug: Atezolizumab; Drug: Paclitaxel; Biological: Pertuzumab; Other: Placebo; Other: Quality-of-Life Assessment; Biological: Trastuzumab Sponsors: National Cancer Institute (NCI); NRG Oncology Recruiting
Condition: Node Positive HER2 Negative Breast Cancer Interventions: Other: Placebo; Drug: Aspirin Sponsors: Alliance for Clinical Trials in Oncology; National Cancer Institute (NCI); United States Department of Defense; Bayer; Canadian Cancer Trials Group Recruiting
Condition: Breast Carcinoma Interventions: Other: Health Education Program; Other: Weight Loss Intervention Sponsors: Alliance for Clinical Trials in Oncology; National Cancer Institute (NCI); Division of Cancer Control; NIH Biomarker, Imaging and Quality of Life Studies Funding Program (BIQSFP); Canadian Cancer Trials Group Recruiting
Conditions: Dyspnea; Fatigue; Nausea and Vomiting; Pain; Stage IV Breast Cancer Interventions: Radiation: Stereotactic Radiosurgery; Procedure: Therapeutic Conventional Surgery; Other: Laboratory Biomarker Analysis Sponsors: NRG Oncology; National Cancer Institute (NCI) Recruiting
Condition: Carotid Stenosis Interventions: Procedure: Carotid endarterectomy (CEA); Device: Carotid Stenting (CAS); Other: Intensive Medical Management - no CEA; Other: Intensive Medical Management - no CAS Sponsors: Thomas G. Brott, M.D.; National Institute of Neurological Disorders and Stroke (NINDS) Recruiting
Condition: Multiple Myeloma in Relapse Interventions: Drug: pomalidomide; Drug: ixazomib; Drug: dexamethasone Sponsors: Alliance for Clinical Trials in Oncology; National Cancer Institute (NCI); Celgene Corporation; Millennium Pharmaceuticals, Inc. Recruiting
Conditions: Stage IB Breast Cancer; Stage II Breast Cancer Interventions: Radiation: regional nodal XRT; Radiation: chestwall XRT; Radiation: WBI Sponsors: NSABP Foundation Inc; National Cancer Institute (NCI); Radiation Therapy Oncology Group Recruiting
Conditions: Estrogen Receptor-negative Breast Cancer; Progesterone Receptor-negative Breast Cancer; Stage IA Breast Cancer; Stage IB Breast Cancer; Stage II Breast Cancer; Triple-negative Breast Cancer Interventions: Procedure: Breast surgery; Procedure: Magnetic resonance imaging; Procedure: Mammography Sponsors: Alliance for Clinical Trials in Oncology; National Cancer Institute (NCI); American College of Radiology Imaging Network Recruiting
Condition: Brain and Central Nervous System Tumors Interventions: Drug: concomitant temozolomide (TMZ); Radiation: radiotherapy; Drug: procarbazine; Drug: adjuvant temozolomide (TMZ); Drug: CCNU; Drug: vincristine Sponsors: Alliance for Clinical Trials in Oncology; National Cancer Institute (NCI); European Organisation for Research and Treatment Center (EORTC); Canadian Cancer Trials Group Recruiting
Condition: Lung Cancer Interventions: Radiation: Standard Radiation Dose Therapy; Drug: cisplatin; Drug: etoposide; Radiation: High Radiation Dose Therapy; Drug: carboplatin Sponsors: Alliance for Clinical Trials in Oncology; National Cancer Institute (NCI) Recruiting
Condition: Cardiovascular Diseases Intervention: Device: ABIOMED, Inc. hemodynamic support devices Sponsors: Abiomed Inc.; Beth Israel Deaconess Medical Center; Yale University Recruiting
Conditions: Graft-versus-host Disease; Acute-graft-versus-host Disease Interventions: Drug: Defibrotide; Drug: Standard of Care Sponsor: Jazz Pharmaceuticals Recruiting
Condition: Early Breast Cancer Intervention: Radiation: Boost to the tumour bed Sponsors: University College, London; National Institute for Health Research, United Kingdom Recruiting
Conditions: Childhood Malignant Neoplasm; Cognitive Side Effects of Cancer Therapy Interventions: Procedure: Cognitive Assessment; Other: Quality-of-Life Assessment Sponsors: Children's Oncology Group; National Cancer Institute (NCI) Recruiting